Evidence map›Paper›PMID 41692781›Full record

ArticleCell communication and signaling : CCS2026

SLC1A5-mediated kynurenine metabolism drives AHR-FANCD2 axis to remodel chromatin and induce T cell exhaustion in lung adenocarcinoma.

Yifei Zhu, Haoji Wang, Yanxi Yao, Hongdou Ding, Li Xu, Xinnan Xu

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yifei Zhu *Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
Haoji Wang *Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanxi Yao *Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
Hongdou DingDepartment of Thoracic Surgery, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China. tjdhd1990@126.com.
Li XuDepartment of Thoracic Surgery, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China. draragorn@163.com.
Xinnan XuDepartment of Thoracic Surgery, School of Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China. fkxx07@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKynurenine, a byproduct of tryptophan breakdown, is linked to immune suppression during cancer development. This study explores the involvement of the amino acid transporter solute carrier family 1 member 5 (SLC1A5) in kynurenine-mediated T cell exhaustion in LUAD and delves into its functional mechanism.

methodsRNA-sequencing analysis was employed to identify transcriptome differences between T progenitor and terminal exhausted T cells (TPEX vs. TEX). The SLC1A5 expression was detected in T cells following L-kynurenine (L-ky) treatment. Mouse LUAD cells LLC were implanted into wild-type (WT), SLC1A5 knockout (SLC1A5

resultsSLC1A5 is upregulated in TEX, and its expression in CD8

conclusionThis study suggests that SLC1A5 is upregulated in TEX, which modulates kynurenine metabolism and induces T cell exhaustion through the AHR-FANCD2 axis-mediated chromatin remodeling.

Indexed as

Amino Acid Transport System ASCChromatin Assembly and DisassemblyKynurenineLung NeoplasmsMinor Histocompatibility AntigensReceptors, Aryl HydrocarbonAnimalsCD8-Positive T-LymphocytesCell Line, TumorHumansMiceMice, KnockoutT-Cell ExhaustionAmino Acid Transport System ASCKynurenineMinor Histocompatibility AntigensReceptors, Aryl HydrocarbonSLC1A5 protein, humanSlc1a5 protein, mouseAHR-FANCD2 interactionCD8+ T cell exhaustionKynurenineLUADSLC1A5

Identifiers

PMID41692781
PMCPMC13014849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.